Ahmadieh, H., et al.,
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
BMC Ophthalmol, 2007. 7: p. 10.

Apte, R.S.
Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.
Int Ophthalmol, 2007.

Arroyo, J.G.,
Towards a rational approach to combination therapy for neovascular age-related macular degeneration.
Br J Ophthalmol, 2007. 91(2): p. 130-1.

Augustin, A.J., S. Puls, and I. Offermann
Triple therapy for choroidal neovascularization due to agerelated macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
Retina, 2007. 27(2): p. 133-40.

Blick, S. K. Keating, G. M. Wagstaff, A. J.
Ranibizumab.
Drugs, 2007. 67(8): p. 1199-206.

Bakri, S.J. and A.S. Kitzmann
Retinal pigment epithelial tear after intravitreal ranibizumab.
Am J Ophthalmol, 2007. 143(3): p. 505-7.

Boyer, D.S., et al.
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Ophthalmology, 2007. 114(2): p. 246-52.

Brown, M.M., G.C. Brown, and H. Brown
Value-based medicine and interventions for macular degeneration.
Curr Opin Ophthalmol, 2007. 18(3): p. 194-200.

Carvounis, P.E., A.C. Kopel, and M.S. Benz
Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
Am J Ophthalmol, 2007. 143(3): p. 504-5

Chakravarthy, U. and J.I. Lim
New treatments for neovascular acute macular degeneration.
Bmj, 2007. 334(7588): p. 269-70.

Chan, C.K., et al.,
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Retina, 2007. 27(5): p. 541-51.

Chang, L. K. Sarraf, D.
Tears of the retinal pigment epithelium: an old problem in a new era.
Retina, 2007. 27(5): p. 523-34

Chen, C.Y., T.Y. Wong, and W.J. Heriot,
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.
Am J Ophthalmol, 2007. 143(3): p. 510-2.

Chen, E., R.S. Kaiser, and J.F. Vander
Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.
Retina, 2007. 27(4): p. 445-50.

Cheung, C.M.P., K. K. Yang, Y.,
Estimating the potential impact of using intravitreal angiostatic agents for wet macular degeneration on service capacity in a large retinal referral centre.
Eye, 2007.

Cohen, S.Y., et al.,
Monitoring anti-VEGF drugs for treatment of exudative AMD.
J Fr Ophtalmol, 2007. 30(4): p. 330-4.

Douglas, I.J., et al.,
A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology, 2007. 114(6): p. 1164-9.

Emerson, M.V.L., et al.
Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
Retina, 2007. 27(4): p. 439-44.

Fung, A.E., et al.
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Am J Ophthalmol, 2007. 143(4): p. 566-83.

Goff, M.J., et al.,
Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Retina, 2007. 27(4): p. 432-8.

Gomi, F., et al.,
One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients.
Ophthalmology, 2007

Han, M.G., et al.
Age-related structural abnormalities in the human retina-choroid complex revealed by two-photon excited autofluorescence imaging.
J Biomed Opt, 2007. 12(2): p. 024012.

Hahn, R., et al.,
Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration.
Ophthalmologe, 2007.

Hannan, S.R., et al.,
Retinal pigment epithelial tear following intravitreal bevacizumab for choroidal neovascular membrane due to age-related macular degeneration.
Br J Ophthalmol, 2007. 91(7): p. 977-8.

Hayek, S.
First clinical experience with anecortave acetate (Retaane)
Klin Monatsbl Augenheilkd, 2007, apr., 224(4) : p 279-81

Ishikawa, K.K.,et al.
Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy.
Invest Ophthalmol Vis Sci, 2007. 48(5): p. 2254-9.

Jampol, L.M.
Bevacizumab vs Ranibizumab Treatment for Age-Related Macular Degeneration: A Head-to-Head Comparison Is Needed.
Arch Ophthalmol, 2007. 125(4): p. 557-8.

Joeres, S., et al.
Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration.
Eye, 2007.

Joussen, A.M., et al.
Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy.
Ophthalmology, 2007. 114(3): p. 551-60.

Kaiser, P.K. and D.V. Do
Ranibizumab for the treatment of neovascular AMD.
Int J Clin Pract, 2007. 61(3): p. 501-9.

Kiss, C., et al.
Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
Acta Ophthalmol Scand, 2007.

Klein, R. Knudtson, M. D. Klein, B. E.
Statin Use and the Five-Year Incidence and Progression of Age-related Macular Degeneration.
Am J Ophthalmol, 2007. 144(1): p. 1-6.

Kvanta, A.
New treatments for neovascular age-related macular degeneration: when should we use them?
Acta Ophthalmol Scand, 2007. 85(1): p. 5.

Kyo, T.Y., et al.
Assessment of the quality of life in patients with age-related macular degeneration 1 year after photodynamic therapy.
Nippon Ganka Gakkai Zasshi, 2007. 111(4): p. 315-21.

La Cour, M.
Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?
Acta Ophthalmol Scand, 2007. 85(1): p. 2-4.

Lazic, R. Gabric, N.
Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Ophthalmology, 2007. 114(6): p. 1179-85.

Lucas, R.S., H.D. McKee, and L.R. Lee
Intravitreal bevacizumab.
Ophthalmology, 2007. 114(2): p. 400; author reply 400-1

Lux, A., et al.,
"Non-responders" to Bevacizumab (AvastinTM) therapy of choroidal neovascular lesions.
Br J Ophthalmol, 2007.

Maaijwee, K., et al.,
Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results.
Graefes Arch Clin Exp Ophthalmol, 2007.

MacLaren, R.E., et al.
Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
Ophthalmology, 2007. 114(3): p. 561-70.

Macugen study group
Pegaptanib 1-Year Systemic Safety Results from a Safety-Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular Degeneration.
Ophthalmology, 2007. may  23th

Maloney SC, et al.
Current and emerging concepts in the management of neovascular age-related
macular degeneration.
Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):147-54.

Manku, K.K., et al.,
Factors influencing poor visual outcome in patients treated with photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
Clin Experiment Ophthalmol, 2007. 35(4): p. 330-4.

Mathews, J.P., et al.,
Retinal pigment epithelial tear following intravitreal injection of bevacizumab (avastin((R))): optical coherence tomography and fluorescein angiographic findings.
Eye, 2007. 21(7): p. 1004-5.

Mills, E., et al.
A randomized trial of Pegaptanib sodium for age-related macular degeneration used an innovative design to explore disease-modifying effects.
J Clin Epidemiol, 2007. 60(5): p. 456-60

Mones, J.M., et al.,
Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab.
Ophthalmic Surg Lasers Imaging, 2007. 38(3): p. 226-8.

Nowak, J.Z. and W. Bienias
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
Postepy Hig Med Dosw (Online), 2007. 61: p. 83-94.

Ogino, T., et al.,
Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year.
Jpn J Ophthalmol, 2007. 51(3): p. 210-5.

Ogino, T.T., M. Imaizumi, H. Okushiba, U.
Study of the causes of poor visual prognosis in photodynamic therapy for age-related macular degeneration.
Nippon Ganka Gakkai Zasshi, 2007. 111(4): p. 309-14.

Petrukhin, K.,
New therapeutic targets in atrophic age-related macular degeneration. Expert Opin
 Ther Targets, 2007. 11(5): p. 625-39.

Ron, Y., et al.
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
Ophthalmologica, 2007. 221(1): p. 57-61.

Ronan, S.M., et al.,
Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Retina, 2007. 27(5): p. 535-40.

Ruiz-Moreno, J.M., J.A. Montero, and M.A. Zarbin
Photodynamic therapy and high-dose intravitreal triamcinolone to treat exsudative ARMD: 2-Year Outcome.
Retina, 2007. 27(4): p. 458-461.

Schadlu, R.K., S. M. Apte, R. S.,
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
Graefes Arch Clin Exp Ophthalmol, 2007.

Smith, T.C. and L. Lee,
Age related macular degeneration - new developments in treatment.
Aust Fam Physician, 2007. 36(5): p. 359-61.

Spaide, R.
Ranibizumab according to need: a treatment for age-related macular degeneration.
Am J Ophthalmol, 2007. 143(4): p. 679-80.

Spitzer, M.S., et al.
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
Graefes Arch Clin Exp Ophthalmol, 2007.

Stefansson, E.l.C.
New drug treatment for age-related macular degeneration.
Laeknabladid, 2007. 93(4): p. 299-301.

Sutter, F.K., et al.,
Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
Klin Monatsbl Augenheilkd, 2007. 224(4): p. 297-9.

Takeda, A.L., et al.,
Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review.
Br J Ophthalmol, 2007.

Tezel, T.H.D.P., L. V Berger, A. S. Kaplan, H. J.,
Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration.
Am J Ophthalmol, 2007. 143(4): p. 584-95.

Tsai, T.H., et al.,
Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
Eye, 2007. 21(6): p. 721-6.

Zuluaga MF, et al.
Synergies of VEGF inhibition and photodynamic therapy in the treatment of
age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1767-72.